Clinical Study Site

Guangzhou, Guangdong 510080

2 studies enrolling now · 2 studies all time

What they study most

Chronic Inflammatory Demyelinating Polyneuropathy, Non-Small Cell Lung Cancer

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) — Recruiting now